down arrow

4basebio Plc

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BMCLYF79
GBP
7.12
-3.57 (-33.41%)

Dec 05

LON

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
PureTech Health Plc
Optibiotix Health Plc
Scancell Holdings Plc
Diaceutics Plc
Ondine Biomedical, Inc.
4basebio Plc
Oxford Biomedica Plc
e-Therapeutics Plc
HemoGenyx Pharmaceuticals Plc
Oxford BioDynamics Plc
Oncimmune Holdings Plc
Why is 4basebio Plc ?
1
Poor Management Efficiency with a low ROE of 2.04%
  • The company has been able to generate a Return on Equity (avg) of 2.04% signifying low profitability per unit of shareholders funds
2
High Debt Company with a Debt to Equity ratio (avg) at times
  • Poor long term growth as Operating profit has grown by an annual rate -197.78% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 2.04% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Operating profit has grown by an annual rate -197.78% of over the last 5 years
4
The company has declared Negative results for the last 5 consecutive quarters
  • INTEREST(HY) At GBP 0.41 MM has Grown at 100.49%
  • OPERATING PROFIT(Q) Lowest at GBP -10.44 MM
  • PRE-TAX PROFIT(Q) Lowest at GBP -6.51 MM
5
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -45.19%, its profits have fallen by -100.8%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is 4basebio Plc for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
4basebio Plc
-100.0%
-1.84
29.06%
FTSE 100
16.5%
1.23
12.99%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
25.77%
EBIT Growth (5y)
-197.78%
EBIT to Interest (avg)
-3.83
Debt to EBITDA (avg)
1.10
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
36.21
Tax Ratio
89.59%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
2.04%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.33
EV to EBIT
-3.04
EV to EBITDA
4.63
EV to Capital Employed
13.17
EV to Sales
0.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-432.61%
ROE (Latest)
-0.89%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Bearish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for 4basebio Plc
Cash and Eqv
Highest at GBP 34.6 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for 4basebio Plc
Pre-Tax Profit
At GBP -6.51 MM has Fallen at -44.97%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (GBP MM)

Net Profit
At GBP -6.61 MM has Fallen at -60.71%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (GBP MM)

Interest
At GBP 0.41 MM has Grown at 100.49%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (GBP MM)

Operating Profit
Lowest at GBP -10.44 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite negative

Operating Profit (GBP MM)

Pre-Tax Profit
Lowest at GBP -6.51 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (GBP MM)

Net Profit
Lowest at GBP -6.61 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (GBP MM)

Raw Material Cost
Grown by 430% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."